A health worker displays the Covid-19 vaccines developed by China's Sinovac. - Xinhua
KUALA LUMPUR: Shares of Pharmaniaga
fell to a low of 88.5 sen on Friday after the government said states will begin dispensing more Pfizer-BioNTech vaccines over Sinovac.
Pharmaniaga has the contract to deliver the Sinovac vaccines and the latest statement worried investors as it had plans to expand the output of the China vaccine later.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
